A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

  1. Mirza, M.R.
  2. González-Martín, A.
  3. Graybill, W.S.
  4. O'Malley, D.M.
  5. Gaba, L.
  6. Stephanie Yap, O.W.
  7. Guerra, E.M.
  8. Rose, P.G.
  9. Baurain, J.-F.
  10. Ghamande, S.A.
  11. Denys, H.
  12. Prendergast, E.
  13. Pisano, C.
  14. Follana, P.
  15. Baumann, K.
  16. Calvert, P.M.
  17. Korach, J.
  18. Li, Y.
  19. Malinowska, I.A.
  20. Gupta, D.
  21. Monk, B.J.
Revista:
Future Oncology

ISSN: 1744-8301,  1479-6694

Any de publicació: 2024

Volum: 20

Número: 13

Pàgines: 799-809

Tipus: Revisió

DOI: 10.2217/FON-2023-0755 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus